Immune response stimulating composition comprising methyl vinyl ethermaleic anhydride copolymer - based nanoparticles

Details for Australian Patent Application No. 2005237269 (hide)

Owner Instituto Cientifico Y Tecnologico De Navarra, S.A

Inventors Gamazo De La Rasilla, Carlos; Ferrer Puga, Marta; Irache Garreta, Juan Manuel; Salman, Hesham H.A.; Gomez Martinez, Sara; San Roman Aberasturi, Beatriz; Sanz Larruga, Maria Luisa; Ochoa Reparaz, Javier

Agent Intellepro

Pub. Number AU-B-2005237269

PCT Pub. Number WO2005/105056

Priority P200401023 29.04.04 ES

Filing date 28 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 11 August 2011

International Classifications

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 39/112 (2006.01) Medicinal preparations containing antigens or antibodies - Salmonella

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105056 Priority application(s): WO2005/105056

7 December 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Immune response stimulating composition comprising methyl vinyl ether-maleic anhydride copolymer - based nanoparticles

11 August 2011 Application Accepted

  Published as AU-B-2005237269

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237270-Pegylated nanoparticles

2005237268-Use of XIKVAV peptides in the preparation of cosmetic compositions which are intended to improve the firmness of the skin by increasing cell adhesion